These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33889008)

  • 1. Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications.
    Rowaiye AB; Okpalefe OA; Onuh Adejoke O; Ogidigo JO; Hannah Oladipo O; Ogu AC; Oli AN; Olofinase S; Onyekwere O; Rabiu Abubakar A; Jahan D; Islam S; Dutta S; Haque M
    J Inflamm Res; 2021; 14():1487-1510. PubMed ID: 33889008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
    Front Immunol; 2022; 13():832394. PubMed ID: 35464491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Inflammatory Cytokines (Interleukin-1 and Interleukin-6) as a Potential Biomarker in the Different Stages of COVID-19 (Mild, Severe, and Critical).
    Ghofrani Nezhad M; Jami G; Kooshkaki O; Chamani S; Naghizadeh A
    J Interferon Cytokine Res; 2023 Apr; 43(4):147-163. PubMed ID: 37062817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
    Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
    Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines and microRNAs in SARS-CoV-2: What do we know?
    Rarani FZ; Rashidi B; Jafari Najaf Abadi MH; Hamblin MR; Reza Hashemian SM; Mirzaei H
    Mol Ther Nucleic Acids; 2022 Sep; 29():219-242. PubMed ID: 35782361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probable Neuropsychological and Cognitive Complications Due to Cytokine Storm in Patients With COVID-19.
    Keshtgar Z; Chalabianloo G; Esmaeili N
    Basic Clin Neurosci; 2023; 14(5):549-564. PubMed ID: 38628831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can
    Choi JH; Lee YH; Kwon TW; Ko SG; Nah SY; Cho IH
    J Ginseng Res; 2022 May; 46(3):337-347. PubMed ID: 35233163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
    Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
    Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.
    Rabiu Abubakar A; Ahmad R; Rowaiye AB; Rahman S; Iskandar K; Dutta S; Oli AN; Dhingra S; Tor MA; Etando A; Kumar S; Irfan M; Gowere M; Chowdhury K; Akter F; Jahan D; Schellack N; Haque M
    Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
    Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
    Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.
    Bahari Z; Jangravi Z; Ghoshooni H; Afarinesh MR; Meftahi GH
    Inflamm Res; 2021 Apr; 70(4):389-405. PubMed ID: 33608746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
    J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fighting the storm: could novel anti-TNFα and anti-IL-6
    Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.